Aerosol delivery to the lung is more efficient using an extension with a standard jet nebulizer than an open-vent jet nebulizer

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 26, Issue 4, 2013, Pages 208-214

  Pitance, L ^a   Reychler, G ^a   Leal, T ^a   Reychler, H ^a   Liistro, G ^a   Montharu, J ^b,c   Diot, P ^b,c   Vecellio, L ^b,c,d  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ DE TOURS   (France)

^c Université Franaois Rabelais   (France)

^d DTF Aerodrug   (France)

Author keywords

aerosol; animal study; bench study; drug deposition; human study; jet nebulizer

Indexed keywords

AMIKACIN;

ADULT; AEROSOL; ANIMAL EXPERIMENT; ARTICLE; BABOON; DRUG DELIVERY SYSTEM; DRUG URINE LEVEL; FILTRATION; HUMAN; JET NEBULIZER; LASER DIFFRACTION; LUNG; MALE; NEBULIZER; NONHUMAN; NORMAL HUMAN; RADIOACTIVITY; SCINTIGRAPHY;

EID: 84880854001     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2012.0994     Document Type: Article

References (24)

1. Hess DR: Nebulizers: principles and performance. Respir Care. 2000;45:609-622. (Pubitemid 30484801)
2. Loffert DT, Ikle D, and Nelson HS: A comparison of commercial jet nebulizers. Chest. 1994;106:1788-1792.
3. Nikander K: Drug delivery systems. J Aerosol Med. 1994;7:S19-S24. (Pubitemid 24295379)
4. Coates AL, MacNeish CF, Lands LC, Meisner D, Kelemen S, and Vadas EB: A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Chest. 1998;113:951-956. (Pubitemid 28216437)
5. Coates AL, Allen PD, MacNeish CF, Ho SL, and Lands LC: Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Chest. 2001;119:1123-1130. (Pubitemid 32679440)
6. Usmani OS, Biddiscombe MF, Nightingale JA, Underwood SR, and Barnes PJ: Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. J Appl Physiol. 2003;95:2106-2112. (Pubitemid 37310397)
7. O'Callaghan C: Problems with drug delivery from nebulizers and spacers. J Aerosol Med. 2005;8:301-302.
8. Bauer A, McGlynn P, Bovet LL, Mims PL, Curry LA, and Hanrahan JP: The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulator. Respir Care. 2009;54:1488-1492.
9. Dennis JH: Drug nebuliser design and performance: breath enhanced jet vs. constant output jet vs. ultrasonic. J Aerosol Med. 1995;8:277-280.
10. Devadason SG, Everard ML, Linto JM, and Le Souef PN: Comparison of drug delivery from conventional versus "Venturi" nebulizers. Eur Respir J. 1997;10:2479-2483. (Pubitemid 28048619)
11. Chatburn RL, and McPeck M: A new system for understanding nebulizer performance. Respir Care. 2007;52:1037-1050.
12. Finlay WH, Stapelton KW, and Zuberbuhler P: Variation in predicter regional lung deposition of salbutamol sulphate between 19 nebulizer types. J Aerosol Med. 1998; 11:65-80. (Pubitemid 28259487)
13. Pitance L, Vecellio L, Leal T, Reychler G, Reychler H, and Liistro G: Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. J Aerosol Med Pulm Drug Deliv. 2010;23:389-396.
14. Pitance L, Vecellio L, Delval G, Reychler G, Reychler H, and Liistro G: Aerosol delivery through tracheostomy tubes: an in vitro study. J Aerosol Med Pulm Drug Deliv. 2012. [Epub ahead of print]
15. Majoral C, Vecellio L, Grimbert D, de Monte M, le Guellec C., Ingremeau V, Minois C, Cordeau E, Paintaud G, Steinberg A, and Diot P: New ipratropium formulation to decrease nebulization time. Respir Med. 2007;101:237-245. (Pubitemid 46075980)
16. Vecellio None L, Grimbert D, Bordenave J, Benoit G, Furet Y, Fauroux B, Boissinot E, de Monte M, Lemarie E, and Diot P: Residual gravimetric method to measure nebulizer output. J Aerosol Med. 2004;17:63-71. (Pubitemid 38520674)
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, and Wanger J: Standardisation of spirometry. Eur Respir J. 2005;26:319-338. (Pubitemid 41079078)
18. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, and Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5-40.
19. Konno K, and Mead J: Measurement of the separate volume changes of rib cage and abdomen during breathing. J Appl Physiol. 1967;22:407-422.
20. Reychler G, Wallemacq P, Rodenstein DO, Cumps J, Leal T, and Liistro G: Comparison of lung deposition of amikacin by intrapulmonary percussive ventilation and jet nebulization by urinary monitoring. J Aerosol Med. 2006;19: 199-207. (Pubitemid 43993386)
21. Martonen TB, Katz IM, and Musante CJ: A nonhuman primate aerosol deposition model for toxicological and pharmaceutical studies. Inhal Toxicol. 2001;13:307-324. (Pubitemid 32410628)
22. Barry PW, and O'Callaghan C: An in vitro analysis of the output of salbutamol from different nebulizers. Eur Respir J. 1999;13:1164-1169. (Pubitemid 29288946)
23. Tiddens H: Matching the device to the patient. Pediatr Pulmonol Suppl. 2004;26:26-29. (Pubitemid 38222398)
24. Wilson RS, and Muers MF: Running a domiciliary nebuliser service. Thorax. 1997;52 Suppl 2:S104-S106. (Pubitemid 27239465)